Patient Guide: A Study of Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of SR604 in Two Participants Groups (Part A: Healthy Participants, and Part B: Participants With Hemophilia A or Hemophilia B)

Why Use Quri.ai for This Trial?

  • ✓ Simplified eligibility checker - know if you qualify in minutes
  • ✓ Direct contact with study coordinators at 10 locations
  • ✓ Plain language explanations of medical terms and procedures
  • ✓ Personalized enrollment support throughout your journey
  • ✓ Free service - no hidden fees or obligations
Trial ID: NCTNCT06349473
Status: 🟢 Enrolling Now
Condition: Hemophilia A, Hemophilia B
Phase: PHASE1

Where You Can Participate

This study is available at 10 locations across the country.

Top locations include:
  • • Glendale, California
  • • Los Angeles, California
  • • Chicago, Illinois
  • • And 7 more locations

Loading interactive enrollment tools...

The full interactive experience will load momentarily

A Study of Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of SR604 in Two Participants Groups (Part A: Healthy Participants, and Part B: Participants With Hemophilia A or Hemophilia B) - Join Clinical Trial NCTNCT06349473

How to Join This Clinical Trial - NCTNCT06349473

Learn how to participate in this PHASE1 trial studying an investigational therapy for Hemophilia A, Hemophilia B. This study is currently enrolling participants.

Am I Eligible for This Clinical Trial?

This clinical research study is looking for participants with Hemophilia A, Hemophilia B. Eligibility requirements include specific age ranges, health status, and medical history. Contact the study team to learn if you qualify.

Condition Being Studied
Hemophilia A, Hemophilia B
Treatment Being Tested
Investigational treatment
Study Phase
PHASE1 - Early safety study
Enrollment Status
Currently enrolling participants
Study Identifier
NCTNCT06349473 - ClinicalTrials.gov Identifier
Sponsored By
Study sponsor

What to Expect as a Participant

Participating in this clinical trial involves:

  • Initial screening to determine eligibility
  • Regular study visits and health assessments
  • Receiving the study treatment or placebo
  • Medical monitoring and follow-up care
  • Contributing to medical research that may help others
  • Potential access to new treatments before they're widely available

Clinical Trial Benefits and Compensation

Participants in this clinical research study may receive:

  • Close medical monitoring by healthcare professionals
  • Access to potential new treatments
  • Compensation for time and travel (varies by study)
  • No-cost study-related medical care
  • The opportunity to help advance medical knowledge

Where Is This Clinical Trial Located?

This study is enrolling participants at 10 locations. Find a study site near you:

Clinical Research Site

Glendale, California 91206 - United States

Status: COMPLETED

Clinical Research Site

Los Angeles, California 90027 - United States

Status: NOT_YET_RECRUITING

Clinical Research Site

Chicago, Illinois 60612 - United States

Status: NOT_YET_RECRUITING

Clinical Research Site

Metairie, Louisiana 70001 - United States

Status: RECRUITING

Clinical Research Site

Ann Arbor, Michigan 48109 - United States

Status: RECRUITING

Clinical Research Site

Saint Louis, Missouri 63110 - United States

Status: RECRUITING

Clinical Research Site

Greenville, North Carolina 27834 - United States

Status: NOT_YET_RECRUITING

Clinical Research Site

Hershey, Pennsylvania 17033 - United States

Status: NOT_YET_RECRUITING

Clinical Research Site

Philadelphia, Pennsylvania 19104 - United States

Status: RECRUITING

Clinical Research Site

Hamilton, Ontario L8N 3Z5 - Canada

Status: NOT_YET_RECRUITING

How to Enroll in This Study

To learn more about participating in this PHASE1 clinical trial for Hemophilia A, Hemophilia B:

  1. Review the eligibility criteria with your healthcare provider
  2. Contact the study team for a pre-screening interview
  3. Schedule an in-person screening visit if eligible
  4. Review and sign the informed consent form
  5. Begin participation in the clinical trial

Why Choose Quri.ai Study Finder

Quri.ai's Study Finder is the leading clinical trial business intelligence platform, helping BD professionals:

  • Discover clinical trials before competitors
  • Access exclusive contact information
  • Track sponsor pipelines and opportunities
  • Connect with decision makers directly
  • Win more business partnerships